Menu Back toSpotlight Symposia: Three Paths to Success in a Post-COVID World

DIA 2021 Global Annual Meeting


Spotlight Symposia: Three Paths to Success in a Post-COVID World

Session Chair(s)

  WCG Clinical Services

WCG Clinical Services

  • United States
- The status of market uptake for select CNS clinical trials by the pharma industry: rejuvenated interest and continued challenges ahead. - Continuously improved solutions are no longer a nice-to-have. - COVID implications on patient selection, study analytics, and placebo response reduction. - The future of CNS drug development.

Speaker(s)

Bob  Dagher

Bob Dagher

  • Chief Medical Officer
  • WCG MedAvante-ProPhase, United States
Mark Gregory Opler, PhD, MPH

Mark Gregory Opler, PhD, MPH

  • Chief Research Officer
  • WCG MedAvante-ProPhase, United States